A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis
Clinical trial NCT01922050 · COMPLETED
Trial details
- NCT number
- NCT01922050
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2014-11-01
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.